Quest Diagnostics Incorporated Company Profile
NYSE: DGXHealth CareMedical SpecialitiesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 230.81 0.00%
Quest Diagnostics at a glance
Quest Diagnostics Incorporated (NYSE: DGX) is a Medical Specialities company in the Health Care sector headquartered in Secaucus, NJ. Quest Diagnostics is led by Mr. James E. Davis and employs about 46,000 people. At a market capitalization of $25.06 billion, it is considered a large-cap company.
DGX is a member of the SP500. Its SEC Central Index Key (CIK) is 0001022079, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Quest Diagnostics do?
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Business description based on the company's public filings.
Company information
- Legal name
- Quest Diagnostics Incorporated
- Ticker
- NYSE: DGX
- Sector
- Health Care
- Industry
- Medical Specialities
- CEO
- Mr. James E. Davis
- Employees
- 46,000
- Headquarters
- 500 Plaza Drive, Secaucus, NJ, United States
- Phone
- 973 520 2700
- Website
- questdiagnostics.com
- Market cap
- $25.06B
- SEC CIK
- 0001022079
- Latest annual report
- 10-K · Feb 26, 2026
Index membership
Companies similar to Quest Diagnostics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LHLabcorp Holdings Inc. | 314.20 | +0.71% | $25.48B | vs DGX |
| GHGuardant Health Inc. | 165.56 | -1.65% | $22.22B | vs DGX |
| CNCCentene Corporation | 64.54 | -0.69% | $31.88B | vs DGX |
| MOHMolina Healthcare Inc | 195.76 | +0.48% | $10.22B | vs DGX |
| OSCROscar Health Inc. Class A | 33.10 | +0.58% | $10.22B | vs DGX |
| ILMNIllumina Inc. | 264.57 | -1.19% | $39.95B | vs DGX |
| HSICHenry Schein Inc. | 84.63 | +1.16% | $9.43B | vs DGX |
| CAICaris Life Sciences Inc. | 27.50 | +1.48% | $7.77B | vs DGX |